(Q47834462)

6 February 2018

title

Immunogenicity and in vitro protective efficacy of a polyepitope Plasmodium falciparum candidate vaccine constructed by epitope shuffling. (English)

1 reference

6 February 2018

main subject

Plasmodium falciparum

1 reference

Qiliang Cai

1

1 reference

6 February 2018

Guiying Peng

2

1 reference

6 February 2018

Lingyi Bu

3

1 reference

6 February 2018

Yahui Lin

4

1 reference

6 February 2018

Lianhui Zhang

5

1 reference

6 February 2018

Sara Lustigmen

6

1 reference

6 February 2018

Heng Wang

7

1 reference

6 February 2018

language of work or name

English

0 references

publication date

21 May 2007

1 reference

6 February 2018

number of pages

11

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

6 February 2018

volume

25

1 reference

6 February 2018

page(s)

5155-5165

1 reference

6 February 2018

issue

28

1 reference

6 February 2018

Conquering the intolerable burden of malaria: what's new, what's needed: a summary.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.085

Evaluation of SPf66 malaria vaccine efficacy in Brazil.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.085

Phase I/IIa safety, immunogenicity, and efficacy trial of NYVAC-Pf7, a pox-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.085

A protein particle vaccine containing multiple malaria epitopes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.085

Immunogenicity and in vitro protective efficacy of a recombinant multistage Plasmodium falciparum candidate vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.085

Influence of adjuvants in inducing immune responses to different epitopes included in a multiepitope, multivalent, multistage Plasmodium falciparum candidate vaccine (FALVAC-1) in outbred mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.085

Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.085

Expression library immunization protects mice against a challenge with virulent rodent malaria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.085

Towards a blood-stage vaccine for malaria: are we following all the leads?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.085

Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.085

Fusion of two malaria vaccine candidate antigens enhances product yield, immunogenicity, and antibody-mediated inhibition of parasite growth in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.085

Immunogenicity of polyepitope libraries assembled by epitope shuffling: an approach to the development of chimeric gene vaccination against malaria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.085

Secretion of Plasmodium falciparum rhoptry protein into the plasma membrane of host erythrocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.085

Expression of an immunologically reactive merozoite surface protein (MSP-1(42)) in E. coli.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.085

Designing and engineering of DNA-vaccine construction encoding multiple CTL-epitopes of major HIV-1 antigens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.085

Long-term multiepitopic cytotoxic-T-lymphocyte responses induced in chimpanzees by combinations of Plasmodium falciparum liver-stage peptides and lipopeptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.085

Bystander help within a polyepitope DNA vaccine improves immune responses to influenza antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.085

Induction of broadly neutralizing antibodies against measles virus mutants using a polyepitope vaccine strategy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.085

Immunity to recombinant plasmodium falciparum merozoite surface protein 1 (MSP1): protection in Aotus nancymai monkeys strongly correlates with anti-MSP1 antibody titer and in vitro parasite-inhibitory activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.085

Immunity to asexual blood stage malaria and vaccine approaches

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.085

Identification of a commonPlasmodium epitope (CPE) recognised by a pan-specific inhibitory monoclonal antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.085

Structural diversity in the Plasmodium falciparum merozoite surface antigen 2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.085

Synthetic peptides based on conserved Plasmodium falciparum antigens are immunogenic and protective against Plasmodium yoelii malaria.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.085

Primary structure of the 175K Plasmodium falciparum erythrocyte binding antigen and identification of a peptide which elicits antibodies that inhibit malaria merozoite invasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.085

Plasmodium falciparum: further characterization of a functionally active region of the merozoite invasion ligand EBA-175.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.085

Analysis of immune responses against T- and B-cell epitopes from Plasmodium falciparum liver-stage antigen 1 in rodent malaria models and malaria-exposed human subjects in India

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.085

Clinical disease, immunity and protection against Plasmodium falciparum malaria in populations living in endemic areas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.085

inferred from DOI database lookup

7 January 2021

based on heuristic

Characterization of human T- and B-cell epitopes in the C terminus of Plasmodium falciparum merozoite surface protein 1: evidence for poor T-cell recognition of polypeptides with numerous disulfide bonds

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.085

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2007.04.085

1 reference

6 February 2018

PubMed ID

17548134

1 reference

6 February 2018